O-GlcNAc: a regulatory post-translational modification

被引:159
|
作者
Wells, L [1 ]
Whalen, SA [1 ]
Hart, GW [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA
关键词
O-GlcNAc; post-translational modification; transcription; signal transduction; apoptosis; neurodegeneration; nutrient sensing; diabetes; Alzheimer's disease; glycosylation;
D O I
10.1016/S0006-291X(03)00175-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta-N-Acetylglucosamine (O-GlcNAc) is a regulatory post-translational modification of nuclear and cytosolic proteins. The enzymes for its addition and removal have recently been cloned and partially characterized. While only about 80 mammalian proteins have been identified to date that carry this modification, it is clear that this represents just a small percentage of the modified proteins. O-GlcNAc has all the properties of a regulatory modification including being dynamic and inducible. The modification appears to modulate transcriptional and signal transduction events. There are also accruing data that O-GlcNAc plays a role in apoptosis and neurodegeneration. A working model is emerging that O-GlcNAc serves as a metabolic sensor that attenuates a cell's response to extracellular stimuli based on the energy state of the cell. In this review, we will focus on the enzymes that add/remove O-GlcNAc, the functional impact of O-GlcNAc modification, and the current working model for O-GlcNAc as a nutrient sensor. (C) 2003 Published by Elsevier Science (USA).
引用
收藏
页码:435 / 441
页数:7
相关论文
共 50 条
  • [21] POST-TRANSLATIONAL MODIFICATION OF PROTEINS
    LODISH, HF
    ENZYME AND MICROBIAL TECHNOLOGY, 1981, 3 (03) : 178 - 188
  • [22] Post-translational modification by SUMO
    Hannoun, Zara
    Greenhough, Sebastian
    Jaffray, Ellis
    Hay, Ronald T.
    Hay, David C.
    TOXICOLOGY, 2010, 278 (03) : 288 - 293
  • [23] Post-translational modification approaches
    Flanagan, Nina
    GENETIC ENGINEERING NEWS, 2006, 26 (15): : 44 - +
  • [24] Post-translational modification and phenotype
    Salovska, Barbora
    Liu, Yansheng
    PROTEOMICS, 2023, 23 (3-4)
  • [25] Post-translational Modification Networks
    van Noort, Vera
    MOLECULAR & CELLULAR PROTEOMICS, 2014, 13 (08) : S34 - S34
  • [26] O-GlcNAc Modification of Proteins and Cancer Metastasis
    Khalaila, Isam
    Yehezkel, Galit
    Cohen, Liz
    Kliger, Adi
    Finkelstein, Ela
    GLYCOBIOLOGY, 2011, 21 (11) : 1492 - 1492
  • [27] O-GlcNac Modification of Human Cardiac α-Actinin
    Leung, Man Ching
    Messer, Andrew E.
    Copeland, O'Neal
    Marston, Steven B.
    BIOPHYSICAL JOURNAL, 2011, 100 (03) : 301 - 301
  • [28] Immune Regulation by the Posttranslational Modification O-GlcNAc
    Pappa, Alexander
    Guerini, Danilo
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2010, 5 (01) : 41 - 48
  • [29] Metabolism and O-GlcNAc modification: mechanisms and regulation
    McClain, Don
    Taylor, Roderick
    Soesanto, Yudi
    Luo, Bai
    AMINO ACIDS, 2009, 37 (01) : 59 - 59
  • [30] O-GlcNAc modification of nucleocytoplasmic proteins and diabetes
    Akimoto Y.
    Hart G.W.
    Hirano H.
    Kawakami H.
    Medical Molecular Morphology, 2005, 38 (2) : 84 - 91